PP9. Cost-quality of life study in inflammatory breast cancer (IBC) out patients receiving high dose intensity chemotherapy with RH-GCSF and stem cell support (PEGASE 2)
P Viens, ML Bouscary, T Palangié, H Roche, M Fabbro, M Janvier, T Delozier, G Macquart-Moulin, JP MoattiVolume:
33
Year:
1997
Language:
english
DOI:
10.1016/s0959-8049(97)85922-9
File:
PDF, 317 KB
english, 1997